Boothbay Fund Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32,757
Closed -$559K 2441
2025
Q3
$559K Buy
+32,757
New +$469K 0.01% 1092
2021
Q3
Sell
-5,961
Closed -$207K 2239
2021
Q2
$207K Buy
+5,961
New +$189K 0.01% 1508
2019
Q3
Sell
-25,306
Closed -$557K 926
2019
Q2
$557K Buy
+25,306
New +$465K 0.05% 386

Other funds holding ZYME

Boothbay Fund Management's ZYME Position: Q4 2025 in Review

Boothbay Fund Management sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 32,757 shares — an estimated $559K sold.

Boothbay Fund Management first reported a position in ZYME in Q2 2019 and held it in 3 quarters. The position peaked at $559K in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

  • Boothbay Fund Management reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 32,757 Zymeworks shares in Q4 2025, an estimated $559K.
  • Boothbay Fund Management first reported a position in Zymeworks in Q2 2019 and held it in 3 quarters.
  • Boothbay Fund Management's Zymeworks position peaked at $559K in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.